Journal Title：Journal Of Personalized Medicine

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., pharmacogenomics/proteomics, systems biology). JPM recognizes that personalized medicine—the assessment of genetic, environmental and host factors that cause variability of individuals—is a challenging, transdisciplinary topic that requires discussions from a range of experts. For a comprehensive perspective of personalized medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.

《個性化醫(yī)學雜志》（JPM；ISSN 2075-4426）是一本國際性開放獲取期刊，旨在將個性化醫(yī)學的各個方面集中到一個平臺上。JPM 發(fā)表與個性化醫(yī)學相關(guān)的前沿、創(chuàng)新性臨床前和轉(zhuǎn)化科學研究和技術(shù)（例如藥物基因組學/蛋白質(zhì)組學、系統(tǒng)生物學）。JPM 認識到個性化醫(yī)學（評估導致個體差異的遺傳、環(huán)境和宿主因素）是一個具有挑戰(zhàn)性的跨學科主題，需要一系列專家的討論。為了全面了解個性化醫(yī)學，JPM 旨在整合分子和轉(zhuǎn)化科學、治療學和診斷學的專業(yè)知識，以及監(jiān)管、社會、倫理和政策方面的討論。我們提供一個論壇，將學術(shù)和臨床研究人員、生物技術(shù)、診斷和制藥公司、衛(wèi)生專業(yè)人員、監(jiān)管和倫理專家以及政府和監(jiān)管機構(gòu)聚集在一起。

Journal Of Personalized Medicine創(chuàng)刊于2011年，由Multidisciplinary Digital Publishing Institute (MDPI)出版商出版，收稿方向涵蓋Medicine - Medicine (miscellaneous)全領域，此刊是中等級別的SCI期刊，所以過審相對來講不是特別難，但是該刊專業(yè)認可度不錯，仍然是一本值得選擇的SCI期刊 。平均審稿速度約First decision after submission: 20.2 days; Acceptance to publication: 1.9 days 11 Weeks ，影響因子指數(shù)3，該期刊近期被列入國際期刊預警名單，請廣大學者慎重選擇。